Identification | Back Directory | [Name]
Palbociclib-d8 | [CAS]
1628752-83-9 | [Synonyms]
PD 0332991-d8 Palbociclib-d8 [2H8]-Palbociclib 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl-2,2,3,3,5,5,6,6-d8)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one | [Molecular Formula]
C24H21D8N7O2 | [MDL Number]
MFCD33023239 | [MOL File]
1628752-83-9.mol | [Molecular Weight]
455.582 |
Hazard Information | Back Directory | [Uses]
Palbociclib-d8 is labelled Palbociclib (P139900), an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
|
Company Name: |
Twochem Co.Ltd.
|
Tel: |
021-58111628 15800915896 |
Website: |
cn.twochem.com |
Company Name: |
Energy Chemical
|
Tel: |
021-58432009 400-005-6266 |
Website: |
http://www.energy-chemical.com |
Company Name: |
Wuhan Topule
|
Tel: |
+86-02787215551 +86-19945035818 |
Website: |
http://www.topule.com/ |
Company Name: |
cjbscvictory
|
Tel: |
13348960310 13348960310 |
Website: |
http://www.weikeqi-biotech.com/ |
|